Related Experiment Videos
Aggregation of dipalmitoylphosphatidylcholine vesicles
Biochemistry
|August 17, 1982
Summary
Below the gel-liquid-crystalline phase transition, dipalmitoylphosphatidylcholine vesicle aggregation is influenced by concentration, temperature, and size. Higher temperatures and larger vesicle sizes (950 A) promote fusion, while increased concentration affects aggregate numbers via bimolecular collisions.
Area of Science:
- Biophysics
- Materials Science
- Physical Chemistry
Background:
- Dipalmitoylphosphatidylcholine (DPPC) vesicles are model systems for studying lipid membrane behavior.
- Understanding vesicle aggregation and fusion is crucial for drug delivery and biomaterial design.
- The gel-liquid-crystalline phase transition significantly impacts lipid vesicle properties.
Purpose of the Study:
- To investigate the aggregation kinetics of DPPC vesicles below their phase transition temperature.
- To determine the influence of vesicle concentration, temperature, and size on aggregation and fusion.
- To develop a model for vesicle-aggregate interactions and fusion mechanisms.
Main Methods:
- Quasi-elastic light scattering (QELS) was employed to analyze vesicle size and aggregation.
- 90-degree light scattering was used to monitor changes in aggregate formation.
- Experiments were conducted across varying DPPC vesicle concentrations, temperatures, and initial vesicle sizes.
Main Results:
- Vesicle concentration influenced the number of aggregates, suggesting a bimolecular collisional mechanism for fusion.
- Increased temperature reduced aggregation, as the disaggregation rate surpassed the aggregation rate.
- Aggregation varied with vesicle size, decreasing for smaller vesicles (up to 700 A) and increasing for larger ones (950 A).
Conclusions:
- A model was proposed where aggregation precedes fusion in DPPC vesicles below the phase transition.
- Collisions between vesicle aggregates act as a trigger for fusion.
- Temperature and vesicle size are critical factors modulating the aggregation-fusion pathway.